Commercially funded and United States-based research is more likely to be published; good-quality studies with negative outcomes are not

作者: Joseph R. Lynch , Mary R.A. Cunningham , Winston J. Warme , Douglas C. Schaad , Fredric M. Wolf

DOI: 10.2106/JBJS.F.01152

关键词: MedicineEvidence-based medicineReceiptOutcome (game theory)Sample size determinationPublication biasBibliometricsCountry of originSurgeryDemographyMEDLINE

摘要: Background: Prior studies implying associations between receipt of commercial funding and positive (significant and/or pro-industry) research outcomes have analyzed only published papers, which is an insufficiently robust approach for assessing publication bias. In this study, we tested the following hypotheses regarding orthopaedic manuscripts submitted review: (1) nonscientific variables, including funding, affect likelihood that a peer-reviewed submission will conclude with report study outcome, (2) other, variables are associated acceptance publication. Methods: All about hip or knee arthroplasty were to The Journal Bone Joint Surgery, American Volume, over seventeen months evaluated determine design, quality, outcome. Analyses carried out identify scientific factors (sample size, level evidence) outcome as well non-scientific (funding source country origin) also performed whether factors, publication. Results: Two hundred nine reviewed. Commercial was not found be (p = 0.668). Studies no more likely than those negative 0.410). higher quality 0.003) included larger sample sizes 0.05). Commercially funded 0.027) United States-based 0.020) published, even though sizes, lower levels evidence 0.24 0.79). Conclusions: review nonfunded studies, These findings contradict most previous analyses (rather submitted) research. origin predict peer beyond what would expected on basis quality. although seemingly superior in fared better peer-review process; may result inflation apparent treatment effects when literature subjected meta-analysis.

参考文章(88)
Lisa A. Bero, Tobacco industry manipulation of research. Public Health Reports. ,vol. 120, pp. 200- 208 ,(2005) , 10.1177/003335490512000215
Iain Chalmers, Jini Hetherington, Curtis L. Meinert, Kay Dickersin, Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics. ,vol. 84, pp. 374- 380 ,(1989)
Meredith Wadman, $100m payout after drug data withheld Nature. ,vol. 388, pp. 703- 703 ,(1997) , 10.1038/41836
Quirin Schiermeier, Novartis goes public with fraud dismissal. Nature. ,vol. 392, pp. 319- 319 ,(1998) , 10.1038/32734
Ehsan Masood, MAFF in a stew over food research plans Nature. ,vol. 392, pp. 319- 319 ,(1998) , 10.1038/32731
Holger Schünemann, Victor M. Montori, Emil H. Schemitsch, Dianne Jackowski, Jason W. Busse, Sheila Sprague, Mohit Bhandari, Derek Mears, Dianne Heels-Ansdell, P.J. Devereaux, Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials Canadian Medical Association Journal. ,vol. 170, pp. 477- 480 ,(2004)